Oruka Therapeutics, Inc. (ORKA)

Oruka Therapeutics Statistics

Total Valuation

ORKA has a market cap or net worth of $2.77 billion. The enterprise value is $2.16 billion.

Market Cap	2.77B
Enterprise Value	2.16B

Important Dates

The next estimated earnings date is Wednesday, May 13, 2026, after market close.

Earnings Date	May 13, 2026
Ex-Dividend Date	n/a

Share Statistics

ORKA has 49.54 million shares outstanding. The number of shares has increased by 171.69% in one year.

Current Share Class	49.54M
Shares Outstanding	49.54M
Shares Change (YoY)	+171.69%
Shares Change (QoQ)	+23.49%
Owned by Insiders (%)	2.94%
Owned by Institutions (%)	88.84%
Float	35.07M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	5.54
P/TBV Ratio	5.63
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 22.37, with a Debt / Equity ratio of 0.00.

Current Ratio	22.37
Quick Ratio	21.92
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -24.69% and return on invested capital (ROIC) is -17.80%.

Return on Equity (ROE)	-24.69%
Return on Assets (ROA)	-17.25%
Return on Invested Capital (ROIC)	-17.80%
Return on Capital Employed (ROCE)	-25.79%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$1.24M
Employee Count	68
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +609.07% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+609.07%
50-Day Moving Average	37.04
200-Day Moving Average	25.51
Relative Strength Index (RSI)	79.63
Average Volume (20 Days)	882,334

Short Selling Information

The latest short interest is 3.64 million, so 7.36% of the outstanding shares have been sold short.

Short Interest	3.64M
Short Previous Month	4.47M
Short % of Shares Out	7.36%
Short % of Float	10.39%
Short Ratio (days to cover)	9.14

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-122.05M
Pretax Income	-105.43M
Net Income	-84.31M
EBITDA	-121.97M
EBIT	-122.05M
Earnings Per Share (EPS)	-$1.85

Balance Sheet

The company has $337.04 million in cash and $1.93 million in debt, with a net cash position of $477.65 million or $9.64 per share.

Cash & Cash Equivalents	337.04M
Total Debt	1.93M
Net Cash	477.65M
Net Cash Per Share	$9.64
Equity (Book Value)	471.93M
Book Value Per Share	9.63
Working Capital	328.48M

Cash Flow

In the last 12 months, operating cash flow was -$88.21 million and capital expenditures -$209,000, giving a free cash flow of -$88.42 million.

Operating Cash Flow	-88.21M
Capital Expenditures	-209,000
Depreciation & Amortization	83,000
Net Borrowing	n/a
Free Cash Flow	-88.42M
FCF Per Share	-$1.78

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ORKA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-171.69%
Shareholder Yield	-171.69%
Earnings Yield	-3.19%
FCF Yield	-3.35%

Analyst Forecast

The average price target for ORKA is $62.67, which is 11.91% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$62.67
Price Target Difference	11.91%
Analyst Consensus	Strong Buy
Analyst Count	12
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	18.88%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on September 3, 2024. It was a reverse split with a ratio of 1:12.

Last Split Date	Sep 3, 2024
Split Type	Reverse
Split Ratio	1:12

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a